Skip to main content
. 2021 Oct 17;45(1):106–115. doi: 10.1038/s41440-021-00752-9

Table 2.

Echocardiographic variables at baseline

ALL Control Febuxostat P value
Number 65 34 31
Echocardiographic variables
 TMF-E 66 [57,80] 64 [57,80] 66 [58,81] 0.480
 Averaged e’ 7.65 [6.25, 9.10] 7.75 [6.95, 10.20] 6.09 [4.80, 7.99] 0.028
 Averaged E/e’ 8.04 [7.01, 10.01] 7.90 [6.32, 9.08] 9.18 [7.86, 11.67] 0.032
 TMF-A 79 [67,91] 83 [69,93] 74 [66,89] 0.430
 E/A 0.79 [0.74, 1.11] 0.77 [0.69, 1.13] 0.86 [0.76, 1.08] 0.302
 Deceleration time 217 [192, 241] 220 [200, 247] 210 [186, 234] 0.349
 LV end-diastolic dimension 48.0 [45.0, 52.0] 48.2 [44.9, 52.3] 47.0 [45.0, 52.0] 0.804
 LV end-systolic dimension 30.1 [27.7, 34.1] 31.0 [27.7, 34.0] 30.0 [27.8, 36.3] 0.946
 LV ejection fraction 63.9 [56.4, 69.0] 64.0 [58.5, 69.0] 63.0 [56.4, 69.0] 0.602
 LV mass index 101 [88, 123] 102 [86, 121] 99 [91, 128] 0.611
Categories of LV hypertrophy 0.774
 Normal 42.9% 47.6% 38.1%
 Concentric remodeling 31.0% 23.8% 38.1%
 Concentric hypertrophy 11.9% 14.3% 9.5%
 Eccentric hypertrophy 14.3% 14.3% 14.3%
 LA volume 58 [45,77] 59 [42,77] 54 [49,70] 0.923

TMF-E early diastolic transmitral flow wave, e’ early mitral annular velocity, TMF-A late diastolic transmitral flow wave, LV left ventricular, LA, left atrial.

Data are presented as median (interquartile range).